Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead

Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead Reuters

Early report Major update Updated Apr 2, 2026, 2:08 PM UTC

Track this event Edit in app More event pages

What changed

Reuters: Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead.

First seen Apr 2, 2026, 2:08 PM UTC Latest source Apr 2, 2026, 2:08 PM UTC

Update 1 3d ago

Reuters •published Apr 2, 2026, 2:08 PM UTC •fetched Apr 2, 2026, 2:43 PM UTC